{"count": 9, "results": [{"_id": "38034222", "pmid": 38034222, "pmcid": "PMC10688235", "title": "Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus", "journal": "Cureus", "authors": ["Tiwari A", "Kumar Singh R", "Satone PD", "Meshram RJ"], "date": "2023-10-26T00:00:00Z", "doi": "10.7759/cureus.47771", "meta_date_publication": "2023 Oct", "meta_volume": "15", "meta_issue": "10", "meta_pages": "e47771", "score": 50263.656, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ @SPECIES_9606 @@@patients@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have been largely seen to be suffering from a @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@deficiency of@@@ @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@vitamin B12@@@. ", "citations": {"NLM": "Tiwari A, Kumar Singh R, Satone PD, Meshram RJ. Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus Cureus. 2023 Oct;15(10):e47771. PMID: 38034222", "BibTeX": "@article{38034222, title={Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus}, author={Tiwari A and Kumar Singh R and Satone PD and Meshram RJ}, journal={Cureus}, volume={15}, number={10}, pages={e47771}}"}}, {"_id": "33290383", "pmid": 33290383, "title": "Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.", "journal": "Psychiatr Genet", "authors": ["Kopel J", "Grooms A", "Ganapathy V", "Clothier J"], "date": "2021-02-01T00:00:00Z", "doi": "10.1097/YPG.0000000000000269", "meta_date_publication": "2021 Feb 1", "meta_volume": "31", "meta_issue": "1", "meta_pages": "32-35", "score": 50252.316, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@, and starvation induce @DISEASE_Seizures @DISEASE_MESH:D012640 @@@seizures@@@ in a @SPECIES_9606 @@@patient@@@ with partial @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@SLC13A5 deficiency@@@: a case of pharmaco-synergistic heterozygosity.", "citations": {"NLM": "Kopel J, Grooms A, Ganapathy V, Clothier J. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity. Psychiatr Genet. 2021 Feb 1;31(1):32-35. PMID: 33290383", "BibTeX": "@article{33290383, title={Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.}, author={Kopel J and Grooms A and Ganapathy V and Clothier J}, journal={Psychiatr Genet}, volume={31}, number={1}, pages={32-35}}"}}, {"_id": "34230443", "pmid": 34230443, "title": "Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum.", "journal": "Psychiatr Genet", "date": "2021-08-01T00:00:00Z", "doi": "10.1097/YPG.0000000000000290", "meta_date_publication": "2021 Aug 1", "meta_volume": "31", "meta_issue": "4", "meta_pages": "143", "score": 50251.113, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@, and starvation induce @DISEASE_Seizures @DISEASE_MESH:D012640 @@@seizures@@@ in a @SPECIES_9606 @@@patient@@@ with partial @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@SLC13A5 deficiency@@@: A case of pharmaco-synergistic heterozygosity: Erratum.", "citations": {"NLM": "Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum. Psychiatr Genet. 2021 Aug 1;31(4):143. PMID: 34230443", "BibTeX": "@article{34230443, title={Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: A case of pharmaco-synergistic heterozygosity: Erratum.}, journal={Psychiatr Genet}, volume={31}, number={4}, pages={143}}"}}, {"_id": "40570636", "pmid": 40570636, "title": "Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.", "journal": "Biochem Biophys Res Commun", "authors": ["Yan C", "Ye Y", "Liu N", "Zhang D", "Du W", "Li Y", "Li G", "Li C", "Li J", "Ma S", "Dai Z", "Xiong Z", "Wang Y", "Men C", "Bi R", "Duan Q", "Xu W", "Husilengtu", "Cao Y", "Du J", "Shi C"], "date": "2025-06-24T00:00:00Z", "doi": "10.1016/j.bbrc.2025.152241", "meta_date_publication": "2025 Jun 24", "meta_volume": "777", "meta_issue": "", "meta_pages": "152241", "score": 50247.15, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also normalized the defects from @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@PDCD10 deficiency@@@, including disruption of tight junctions and excessive proliferation of endothelial cells. ", "citations": {"NLM": "Yan C, Ye Y, Liu N, Zhang D, Du W, Li Y, Li G, Li C, Li J, Ma S, Dai Z, Xiong Z, Wang Y, Men C, Bi R, Duan Q, Xu W, Husilengtu, Cao Y, Du J, Shi C. Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage. Biochem Biophys Res Commun. 2025 Jun 24;777():152241. PMID: 40570636", "BibTeX": "@article{40570636, title={Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.}, author={Yan C and Ye Y and Liu N and Zhang D and Du W and Li Y and Li G and Li C and Li J and Ma S and Dai Z and Xiong Z and Wang Y and Men C and Bi R and Duan Q and Xu W and Husilengtu and Cao Y and Du J and Shi C}, journal={Biochem Biophys Res Commun}, volume={777}, pages={152241}}"}}, {"_id": "32087766", "pmid": 32087766, "pmcid": "PMC7132631", "title": "AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy", "journal": "Mol Ther", "authors": ["Ono H", "Suzuki N", "Kanno SI", "Kawahara G", "Izumi R", "Takahashi T", "Kitajima Y", "Osana S", "Nakamura N", "Akiyama T", "Ikeda K", "Shijo T", "Mitsuzawa S", "Nagatomi R", "Araki N", "Yasui A", "Warita H", "Hayashi YK", "Miyake K", "Aoki M"], "date": "2020-04-08T00:00:00Z", "doi": "10.1016/j.ymthe.2020.02.006", "meta_date_publication": "2020 Apr 8", "meta_volume": "28", "meta_issue": "4", "meta_pages": "1133-1153", "score": 50229.383, "text_hl": "Finally, it was determined that treatment with the @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activator @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improved the muscle phenotype in @SPECIES_7955 @@@zebrafish@@@ and @SPECIES_10090 @@@mouse@@@ models of @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@dysferlin deficiency@@@. ", "citations": {"NLM": "Ono H, Suzuki N, Kanno SI, Kawahara G, Izumi R, Takahashi T, Kitajima Y, Osana S, Nakamura N, Akiyama T, Ikeda K, Shijo T, Mitsuzawa S, Nagatomi R, Araki N, Yasui A, Warita H, Hayashi YK, Miyake K, Aoki M. AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy Mol Ther. 2020 Apr 8;28(4):1133-1153. PMID: 32087766", "BibTeX": "@article{32087766, title={AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy}, author={Ono H and Suzuki N and Kanno SI and Kawahara G and Izumi R and Takahashi T and Kitajima Y and Osana S and Nakamura N and Akiyama T and Ikeda K and Shijo T and Mitsuzawa S and Nagatomi R and Araki N and Yasui A and Warita H and Hayashi YK and Miyake K and Aoki M}, journal={Mol Ther}, volume={28}, number={4}, pages={1133-1153}}"}}, {"_id": "19846797", "pmid": 19846797, "pmcid": "PMC2797962", "title": "Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy", "journal": "Diabetes Care", "authors": ["Wile DJ", "Toth C"], "date": "2010-01-01T00:00:00Z", "doi": "10.2337/dc09-0606", "meta_date_publication": "2010 Jan", "meta_volume": "33", "meta_issue": "1", "meta_pages": "156-61", "score": 50075.53, "text_hl": "The present findings therefore add clinical relevance to the existing literature on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@Cbl deficiency@@@. ", "citations": {"NLM": "Wile DJ, Toth C. Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy Diabetes Care. 2010 Jan;33(1):156-61. PMID: 19846797", "BibTeX": "@article{19846797, title={Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy}, author={Wile DJ and Toth C}, journal={Diabetes Care}, volume={33}, number={1}, pages={156-61}}"}}, {"_id": "22770998", "pmid": 22770998, "title": "Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency.", "journal": "Diabetes Res Clin Pract", "authors": ["Mazokopakis EE", "Starakis IK"], "date": "2012-09-01T00:00:00Z", "doi": "10.1016/j.diabres.2012.06.001", "meta_date_publication": "2012 Sep", "meta_volume": "97", "meta_issue": "3", "meta_pages": "359-67", "score": 50058.277, "text_hl": "In our review, recommendations for diagnosis and management of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@Cbl deficiency@@@ (@DISEASE_Drug_Fever @DISEASE_MESH:D000092582 @@@MICD@@@) in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ based on medical bibliography are presented and discussed.", "citations": {"NLM": "Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012 Sep;97(3):359-67. PMID: 22770998", "BibTeX": "@article{22770998, title={Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency.}, author={Mazokopakis EE and Starakis IK}, journal={Diabetes Res Clin Pract}, volume={97}, number={3}, pages={359-67}}"}}, {"_id": "24908579", "pmid": 24908579, "title": "Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin.", "journal": "Acta Diabetol", "authors": ["Beulens JW", "Hart HE", "Kuijs R", "Kooijman-Buiting AM", "Rutten GE"], "date": "2015-02-01T00:00:00Z", "doi": "10.1007/s00592-014-0597-8", "meta_date_publication": "2015 Feb", "meta_volume": "52", "meta_issue": "1", "meta_pages": "47-53", "score": 50054.254, "text_hl": "However, the influence of both duration and dose of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is unclear. ", "citations": {"NLM": "Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015 Feb;52(1):47-53. PMID: 24908579", "BibTeX": "@article{24908579, title={Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin.}, author={Beulens JW and Hart HE and Kuijs R and Kooijman-Buiting AM and Rutten GE}, journal={Acta Diabetol}, volume={52}, number={1}, pages={47-53}}"}}, {"_id": "31519569", "pmid": 31519569, "title": "Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment.", "journal": "Anticancer Res", "authors": ["Hirayama T", "Nagata Y", "Nishida M", "Matsuo M", "Kobayashi S", "Yoneda A", "Kanetaka K", "Udono H", "Eguchi S"], "date": "2019-09-01T00:00:00Z", "doi": "10.21873/anticanres.13652", "meta_date_publication": "2019 Sep", "meta_volume": "39", "meta_issue": "9", "meta_pages": "4699-4709", "score": 50047.27, "text_hl": "Cell-surface markers, cytokine production, and myeloid@DISEASE_Neural_crest_tumor @DISEASE_MESH:C536408 @@@-derived@@@ suppressor cells (MDSCs) were examined in cells from spleen and peritoneal lavage fluid. RESULTS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-treated @SPECIES_10090 @@@mice@@@ exhibited suppressed intraperitoneal @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ growth and extended survival, and these effects were lost in @SPECIES_10090 @@@mice@@@ with severe combined @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@immunodeficiency@@@. ", "citations": {"NLM": "Hirayama T, Nagata Y, Nishida M, Matsuo M, Kobayashi S, Yoneda A, Kanetaka K, Udono H, Eguchi S. Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment. Anticancer Res. 2019 Sep;39(9):4699-4709. PMID: 31519569", "BibTeX": "@article{31519569, title={Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment.}, author={Hirayama T and Nagata Y and Nishida M and Matsuo M and Kobayashi S and Yoneda A and Kanetaka K and Udono H and Eguchi S}, journal={Anticancer Res}, volume={39}, number={9}, pages={4699-4709}}"}}]}